Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study
暂无分享,去创建一个
C. DeCarli | A. Beiser | A. Charidimou | S. Seshadri | C. Satizabal | S. Demissie | J. Romero | Adlin Pinheiro | O. Ekenze | S. Greenberg | Hugo J. Aparicio | Tiffany F. Kautz
[1] C. DeCarli,et al. MRI-Visible Perivascular Spaces and Risk of Incident Dementia , 2022, Neurology.
[2] A. Charidimou,et al. Aging, prevalence and risk factors of MRI-visible enlarged perivascular spaces , 2022, Aging.
[3] A. Charidimou,et al. Association of Apolipoprotein E ɛ4 Allele with Enlarged Perivascular Spaces , 2022, Annals of neurology.
[4] L. Kuller,et al. Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults , 2021, Neurology.
[5] Y. Okada,et al. Genomics of perivascular space burden unravels early mechanisms of cerebral small vessel disease , 2021, Nature Medicine.
[6] D. Conen,et al. Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates , 2020, Brain communications.
[7] Andrew D. Johnson,et al. 70-year legacy of the Framingham Heart Study , 2019, Nature Reviews Cardiology.
[8] P. Calabresi,et al. Neurofilament light chain as a biomarker in neurological disorders , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[9] S. Black,et al. Understanding the role of the perivascular space in cerebral small vessel disease , 2018, Cardiovascular research.
[10] F. de Leeuw,et al. Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden , 2018, Journal of stroke.
[11] L. Wahlund,et al. Topography and Determinants of Magnetic Resonance Imaging (MRI)‐Visible Perivascular Spaces in a Large Memory Clinic Cohort , 2017, Journal of the American Heart Association.
[12] Ludwig Kappos,et al. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis , 2017, Annals of neurology.
[13] Andreas Charidimou,et al. MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy , 2017, Neurology.
[14] M. Kloss,et al. Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection , 2015, Cerebrovascular Diseases.
[15] P. Wolf,et al. Inflammatory biomarkers, cerebral microbleeds, and small vessel disease , 2015, Neurology.
[16] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[17] D. Y. Lee,et al. Lipoprotein Phospholipase A2 and Cerebral Microbleeds in the Framingham Heart Study , 2012, Stroke.
[18] C. DeCarli,et al. Multiple Biomarkers and Risk of Clinical and Subclinical Vascular Brain Injury: The Framingham Offspring Study , 2012, Circulation.
[19] Karen J. Ferguson,et al. Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.
[20] R. Weller,et al. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.
[21] Steven Warach,et al. Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .
[22] F. Paul,et al. Perivascular spaces--MRI marker of inflammatory activity in the brain? , 2008, Brain : a journal of neurology.
[23] R. Rouhl,et al. Virchow-Robin spaces relate to cerebral small vessel disease severity , 2008, Journal of Neurology.
[24] R. Peters,et al. Ageing and the brain , 2006, Postgraduate Medical Journal.
[25] D. Harvey,et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.